Liver disease is an important cause of mortality in type 2 diabetes mellitus (T2DM). It is
estimated that diabetes is the most common cause of liver disease in the United States. Virtually, …

Background and aims Lobeglitazone (LGZ), a newly researched thiazolidinedione (TZD)
thought to have lesser side effects compared with pioglitazone (PGZ), has been recently …

Objective There are no controlled studies on the role of systemic corticosteroids (CS) in
patients with coronavirus disease 2019 (COVID-19). In the absence of high-quality evidence, …

The Asian-Indian phenotype of type 2 diabetes mellitus is uniquely characterized for cardio-metabolic
risk. In the context of implementing patient-centric holistic cardio-metabolic risk …

Aim The definition and management of asymptomatic hyperuricemia has been an area of
controversy for many decades. Debate persists regarding the benefit of treating all cases of …

Background and aims As the Coronavirus disease 2019 (COVID-19) pandemic unravels
rapidly, there is a glut of confusing and divergent scientific information emanating from differing …

The current diabetes management strategies not only aim at controlling glycaemic parameters
but also necessitate continuous medical care along with multifactorial risk reduction …

Aim To develop an evidence-based expert group opinion on the role of insulin motivation to
overcome insulin distress during different stages of insulin therapy and to propose a …

Obstructive sleep apnea (OSA) is an underrated but common disorder with higher
prevalence in those with obesity. Apart from weight-related anatomical obstruction, there are …

hyperglycaemia is an indicator of poor clinical outcome and mortality in patients with or without
a history of diabetes in hospitalised patients in non-critical care condition. A consensus …